Mayo, GE, Deloitte join to expand personalized medicine

(By Jessica Kim Cohen for Becker’s Hospital Review)

Vineti, a cell and gene therapy platform, and Deloitte, an audit and consulting firm, are collaborating to bring personalized medicine solutions to life sciences companies, healthcare providers and patients. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.